A Comparison of the Effects of Different Typographical Methods on the Recognizability of Printed Drug NamesOR, Calvin K. L; HAILIANG WANG.Drug safety. 2014, Vol 37, Num 5, pp 351-359, issn 0114-5916, 9 p.Article

Acute Pancreatitis in Patients with Type 2 Diabetes Mellitus Treated with Dipeptidyl Peptidase-4 Inhibitors: A Population-Based Nested Case-Control StudyCHOU, Hsin-Chun; CHEN, Wen-Wen; HSIAO, Fei-Yuan et al.Drug safety. 2014, Vol 37, Num 7, pp 521-528, issn 0114-5916, 8 p.Article

Association Between Use of Multiple Psychoactive Medicines and Hospitalization for Falls: Retrospective Analysis of a Large Healthcare Claim DatabasePRATT, Nicole L; RAMSAY, Emmae N; KALISCH ELLETT, Lisa M et al.Drug safety. 2014, Vol 37, Num 7, pp 529-535, issn 0114-5916, 7 p.Article

Association of Statin Use with Sleep Disturbances: Data Mining of a Spontaneous Reporting Database and a Prescription DatabaseTAKADA, Mitsutaka; FUJIMOTO, Mai; YAMAZAKI, Kohei et al.Drug safety. 2014, Vol 37, Num 6, pp 421-431, issn 0114-5916, 11 p.Article

Benefit-Risk Assessment of Orlistat in the Treatment of ObesitySUMITHRAN, Priya; PROIETTO, Joseph.Drug safety. 2014, Vol 37, Num 8, pp 597-608, issn 0114-5916, 12 p.Article

Digital Drug Safety Surveillance: Monitoring Pharmaceutical Products in TwitterFREIFELD, Clark C; BROWNSTEIN, John S; MENONE, Christopher M et al.Drug safety. 2014, Vol 37, Num 5, pp 343-350, issn 0114-5916, 8 p.Article

Drug-Induced HyperkalemiaCHAKER BEN SALEM; BADREDDINE, Atef; FATHALLAH, Neila et al.Drug safety. 2014, Vol 37, Num 9, pp 677-692, issn 0114-5916, 16 p.Article

EU's New Pharmacovigilance Legislation: Considerations for BiosimilarsCALVO, Begoña; ZUNIGA, Leyre.Drug safety. 2014, Vol 37, Num 1, pp 9-18, issn 0114-5916, 10 p.Article

Improved Statistical Signal Detection in Pharmacovigilance by Combining Multiple Strength-of-Evidence Aspects in vigiRank: Retrospective Evaluation against Emerging Safety SignalsCASTER, Ola; JUHLIN, Kristina; WATSON, Sarah et al.Drug safety. 2014, Vol 37, Num 8, pp 617-628, issn 0114-5916, 12 p.Article

Ongoing Challenges in PharmacovigilanceDAL PAN, Gerald J.Drug safety. 2014, Vol 37, Num 1, pp 1-8, issn 0114-5916, 8 p.Article

Performance of Probabilistic Method to Detect Duplicate Individual Case Safety ReportsTREGUNNO, Philip Michael; FINK, Dorthe Bech; FERNANDEZ-FERNANDEZ, Cristina et al.Drug safety. 2014, Vol 37, Num 4, pp 249-258, issn 0114-5916, 10 p.Article

Self-Medication with Over-the-Counter and Prescribed Drugs Causing Adverse-Drug-Reaction-Related Hospital Admissions: Results of a Prospective, Long-Term Multi-Centre StudySCHMIEDL, Sven; ROTTENKOLBER, Marietta; HASFORD, Joerg et al.Drug safety. 2014, Vol 37, Num 4, pp 225-235, issn 0114-5916, 11 p.Article

Methodology to Assess Clinical Liver Safety DataMERZ, Michael; LEE, Kwan R; KULLAK-UBLICK, Gerd A et al.Drug safety. 2014, Vol 37, issn 0114-5916, S33-S45, SUP1Article

Pharmacotherapy of Type 2 Diabetes Mellitus: An Update on Drug-Drug InteractionsAMIN, Muhammad; SUKSOMBOON, Naeti.Drug safety. 2014, Vol 37, Num 11, pp 903-919, issn 0114-5916, 17 p.Article

Safety Profile of Dapagliflozin for Type 2 Diabetes: Pooled Analysis of Clinical Studies for Overall Safety and Rare EventsPTASZYNSKA, Agata; JOHNSSON, Kristina M; PARIKH, Shamik J et al.Drug safety. 2014, Vol 37, Num 10, pp 815-829, issn 0114-5916, 15 p.Article

Stimulated Reporting: The Impact of US Food and Drug Administration-Issued Alerts on the Adverse Event Reporting System (FAERS)HOFFMAN, Keith B; DEMAKAS, Andrea R; DIMBIL, Mo et al.Drug safety. 2014, Vol 37, Num 11, pp 971-980, issn 0114-5916, 10 p.Article

Assessment of Case Definitions for Identifying Acute Liver Injury in Large Observational DatabasesKATZ, Aaron J; RYAN, Patrick B; RACOOSIN, Judith A et al.Drug safety. 2013, Vol 36, Num 8, pp 651-661, issn 0114-5916, 11 p.Article

Cardiovascular Safety of Tyrosine Kinase Inhibitors: With a Special Focus on Cardiac Repolarisation (QT Interval)SHAH, Rashmi R; MORGANROTH, Joel; SHAH, Devron R et al.Drug safety. 2013, Vol 36, Num 5, pp 295-316, issn 0114-5916, 22 p.Article

Characterization of Statin-Associated Myopathy Case Reports in Thailand Using the Health Product Vigilance Center DatabaseBOONMUANG, Pornwalai; NATHISUWAN, Surakit; CHAIYAKUNAPRUK, Nathorn et al.Drug safety. 2013, Vol 36, Num 9, pp 779-787, issn 0114-5916, 9 p.Article

Hepatotoxicity of Tyrosine Kinase Inhibitors: Clinical and Regulatory PerspectivesSHAH, Rashmi R; MORGANROTH, Joel; SHAH, Devron R et al.Drug safety. 2013, Vol 36, Num 7, pp 491-503, issn 0114-5916, 13 p.Article

How Do Patients Contribute to Signal Detection?: A Retrospective Analysis of Spontaneous Reporting of Adverse Drug Reactions in the UK's Yellow Card SchemeHAZELL, Lorna; CORNELIUS, Victoria; HANNAFORD, Philip et al.Drug safety. 2013, Vol 36, Num 3, pp 199-206, issn 0114-5916, 8 p.Article

Implementing Ecopharmacovigilance in Practice: Challenges and Potential OpportunitiesHOLM, Gisela; SNAPE, Jason R; MURRAY-SMITH, Richard et al.Drug safety. 2013, Vol 36, Num 7, pp 533-546, issn 0114-5916, 14 p.Article

Probabilistic Record Linkage for Monitoring the Safety of Artemisinin-Based Combination Therapy in the First Trimester of Pregnancy in SenegalDELLICOUR, Stephanie; BRASSEUR, Philippe; THORN, Per et al.Drug safety. 2013, Vol 36, Num 7, pp 505-513, issn 0114-5916, 9 p.Article

Reports of Sexual Disorders Related to Serotonin Reuptake Inhibitors in the French Pharmacovigilance Database: An Example of UnderreportingTRENQUE, Thierry; MAURA, Géric; HERLEM, Emmanuelle et al.Drug safety. 2013, Vol 36, Num 7, pp 515-519, issn 0114-5916, 5 p.Article

The Additional Value of an E-Mail to Inform Healthcare Professionals of a Drug Safety Issue: A Randomized Controlled Trial in the NetherlandsPIENING, Sigrid; DE GRAEFF, Pieter A; STRAUS, Sabine M. J. M et al.Drug safety. 2013, Vol 36, Num 9, pp 723-731, issn 0114-5916, 9 p.Article